Free Trial

Mangoceuticals (MGRX) Short Interest Ratio & Short Volume

Mangoceuticals logo
$1.61 -0.05 (-3.01%)
Closing price 03:59 PM Eastern
Extended Trading
$1.62 +0.01 (+0.62%)
As of 04:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Mangoceuticals Short Interest Data

Mangoceuticals (MGRX) has a short interest of 173,100 shares, representing 5.71% of the float (the number of shares available for trading by the public). This marks a -29.32% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.7, indicating that it would take 0.7 days of the average trading volume of 272,151 shares to cover all short positions.

Current Short Interest
173,100 shares
Previous Short Interest
244,900 shares
Change Vs. Previous Month
-29.32%
Dollar Volume Sold Short
$346,200.00
Short Interest Ratio
0.7 Days to Cover
Last Record Date
April 15, 2025
Outstanding Shares
5,169,000 shares
Float Size
3,030,000 shares
Short Percent of Float
5.71%
Today's Trading Volume
84,681 shares
Average Trading Volume
272,151 shares
Today's Volume Vs. Average
31%
Short Selling Mangoceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Mangoceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

MGRX Short Interest Over Time

MGRX Days to Cover Over Time

MGRX Percentage of Float Shorted Over Time

Mangoceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/2025173,100 shares $346,200.00 -29.3%5.7%0.7 $2.00
3/31/2025244,900 shares $477,555.00 +237.3%7.1%1.6 $1.95
3/15/202572,600 shares $283,866.00 +15.8%2.5%0.5 $3.91
2/28/202562,700 shares $258,951.00 -12.3%2.6%0.6 $4.13
2/15/202571,500 shares $346,060.00 +91.7%5.9%0.7 $4.84
1/31/202537,300 shares $113,019.00 +63.6%3.1%0.4 $3.03
1/15/202522,800 shares $58,140.00 -46.0%1.9%0.2 $2.55
12/31/202442,200 shares $102,124.00 -23.1%2.4%0.3 $2.42
12/15/202454,900 shares $143,289.00 -55.8%4.0%0.1 $2.61
11/30/2024124,200 shares $310,500.00 -18.8%9.1%0.3 $2.50
11/15/2024152,900 shares $353,199.00 -21.4%11.2%0.4 $2.31
10/31/2024194,400 shares $460,728.00 +839.1%15.3%0.6 $2.37
10/15/202420,700 shares $822,514.50 -79.6%1.6%0.1 $39.74
9/30/2024101,600 shares $23,977.60 -50.2%0.5%0 $0.24
9/15/2024203,900 shares $55,053.00 +62.1%1.1%0.2 $0.27
8/31/2024125,800 shares $30,179.42 -72.8%0.8%0.1 $0.24
8/15/2024462,500 shares $148,000.00 +138.7%2.8%0.3 $0.32
7/31/2024193,800 shares $79,070.40 -70.5%1.4%0 $0.41
7/15/2024657,700 shares $253,740.66 +430.8%4.7%0.1 $0.39
6/30/2024123,900 shares $37,665.60 -40.0%0.9%0 $0.30
6/15/2024206,500 shares $66,059.35 +67.9%1.5%0 $0.32
5/31/2024123,000 shares $48,412.80 +353.9%0.9%0 $0.39
5/15/202427,100 shares $5,934.90 -40.7%0.2%0 $0.22
4/30/202445,700 shares $11,109.67 -76.9%0.3%0.1 $0.24
4/15/2024197,600 shares $48,214.40 -71.5%1.5%0.2 $0.24
3/31/2024692,100 shares $150,117.18 +364.2%5.3%0.6 $0.22
3/15/2024149,100 shares $26,405.61 +16.0%1.2%0.1 $0.18
2/29/2024128,500 shares $28,861.10 -81.0%1.1%0.1 $0.22
2/15/2024674,500 shares $158,844.75 +75.4%5.5%0.8 $0.24
1/31/2024384,500 shares $138,804.50 +104.0%4.0%0.5 $0.36
1/15/2024188,500 shares $57,492.50 +195.0%2.6%0.3 $0.31
12/31/202363,900 shares $17,693.91 -57.9%0.9%0.1 $0.28
12/15/2023151,800 shares $46,602.60 +204.8%2.1%0.4 $0.31
11/30/202349,800 shares $36,802.20 +333.0%0.7%0.2 $0.74
11/15/202311,500 shares $5,012.85 -90.4%0.2%0 $0.44
10/31/2023120,300 shares $75,789.00 +620.4%1.7%0.5 $0.63
10/15/202316,700 shares $10,688.00 +153.0%0.2%0.1 $0.64
9/30/20236,600 shares $5,613.30 -82.8%0.1%0.1 $0.85
9/15/202338,400 shares $38,016.00 +18.5%0.6%0.4 $0.99
8/31/202332,400 shares $40,176.00 -22.5%0.5%0 $1.24
Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.

All the details are waiting for you now — but you need to act before the May 1st funding window clos
8/15/202341,800 shares $45,562.00 +5.8%0.6%0 $1.09
7/31/202339,500 shares $45,030.00 -13.9%0.6%0 $1.14
7/15/202345,900 shares $77,112.00 -51.9%0.8%0 $1.68
6/30/202395,400 shares $174,582.00 -79.6%1.6%0 $1.83
6/15/2023468,400 shares $726,020.00 +187.5%7.8%0.2 $1.55
5/31/2023162,900 shares $182,448.00 +10.4%2.9%0 $1.12
5/15/2023147,500 shares $181,425.00 No Change2.6%0 $1.23

MGRX Short Interest - Frequently Asked Questions

What is Mangoceuticals' current short interest?

Short interest is the volume of Mangoceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 173,100 shares of MGRX short. 5.71% of Mangoceuticals' shares are currently sold short. Learn More on Mangoceuticals' current short interest.

What is a good short interest ratio for Mangoceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MGRX shares currently have a short interest ratio of 1.0. Learn More on Mangoceuticals's short interest ratio.

What is a good short interest percentage for Mangoceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.71% of Mangoceuticals' floating shares are currently sold short.

Is Mangoceuticals' short interest increasing or decreasing?

Mangoceuticals saw a decline in short interest in April. As of April 15th, there was short interest totaling 173,100 shares, a decline of 29.3% from the previous total of 244,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Mangoceuticals' float size?

Mangoceuticals currently has issued a total of 5,169,000 shares. Some of Mangoceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Mangoceuticals currently has a public float of 3,030,000 shares.

How does Mangoceuticals' short interest compare to its competitors?

5.71% of Mangoceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to Mangoceuticals: Burning Rock Biotech Limited (0.48%), Concord Medical Services Holdings Limited (0.78%), Enzo Biochem, Inc. (0.97%), BioRestorative Therapies, Inc. (3.82%), Kindly MD, Inc. (4.18%), Ontrak, Inc. (0.89%), BioNexus Gene Lab Corp. (26.50%), Aclarion, Inc. (6.28%), ATI Physical Therapy, Inc. (5.31%), Vsee Health, Inc. (0.63%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks.

What does it mean to sell short Mangoceuticals stock?

Short selling MGRX is an investing strategy that aims to generate trading profit from Mangoceuticals as its price is falling. MGRX shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Mangoceuticals?

A short squeeze for Mangoceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MGRX, which in turn drives the price of the stock up even further.

How often is Mangoceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MGRX, twice per month. The most recent reporting period available is April, 15 2025.




This page (NASDAQ:MGRX) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners